BR112014019602A8 - USE OF CARAMBOLA EXTRACT AS A CPT1 MODULATOR AND COMPOSITIONS THEREOF - Google Patents

USE OF CARAMBOLA EXTRACT AS A CPT1 MODULATOR AND COMPOSITIONS THEREOF

Info

Publication number
BR112014019602A8
BR112014019602A8 BR112014019602A BR112014019602A BR112014019602A8 BR 112014019602 A8 BR112014019602 A8 BR 112014019602A8 BR 112014019602 A BR112014019602 A BR 112014019602A BR 112014019602 A BR112014019602 A BR 112014019602A BR 112014019602 A8 BR112014019602 A8 BR 112014019602A8
Authority
BR
Brazil
Prior art keywords
modulator
compositions
carambola
cpt1
extract
Prior art date
Application number
BR112014019602A
Other languages
Portuguese (pt)
Other versions
BR112014019602A2 (en
Inventor
S Hwang Cheng
Yim Sungham
Santhanam Uma
W Lyga John
Jean Paufique M
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of BR112014019602A2 publication Critical patent/BR112014019602A2/pt
Publication of BR112014019602A8 publication Critical patent/BR112014019602A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MÉTODO COSMÉTICO PARA MELHORAR A CONDIÇÃO DE UMA PELE TENDO LIPÍDIOS EM EXCESSO, COMPOSIÇÃO COSMÉTICA E USOS DO EXTRATO DE CARAMBOLA COMO UM MODULADOR DE CPT-1. A presente invenção descreve métodos para melhorar a aparência da pele, particularmente, por tratamento, melhora, prevenção, atraso, e/ou aperfeiçoamento de um ou mais sinais de acúmulo em excesso e/ou produção de gordura subcutânea, como celulite, e condições relacionadas com a celulite, por aplicação tópica de composições compreendendo um extrato aquoso estimulante de Carnitina Palmitoil Transferase-1 (CPT-1) da folha de Averrhoa carambola, opcionalmente com agentes antilipídicos adicionais.COSMETIC METHOD FOR IMPROVING THE CONDITION OF A SKIN HAVING EXCESS OF LIPIDS, COSMETIC COMPOSITION AND USES OF CARAMBOLA EXTRACT AS A CPT-1 MODULATOR. The present invention describes methods for improving the appearance of the skin, particularly by treating, ameliorating, preventing, delaying, and/or ameliorating one or more signs of excess accumulation and/or production of subcutaneous fat, such as cellulite, and related conditions. with cellulite, by topical application of compositions comprising a stimulating aqueous extract of Carnitine Palmitoyl Transferase-1 (CPT-1) from the leaf of Averrhoa carambola, optionally with additional antilipid agents.

BR112014019602A 2012-02-29 2012-02-29 USE OF CARAMBOLA EXTRACT AS A CPT1 MODULATOR AND COMPOSITIONS THEREOF BR112014019602A8 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/027065 WO2013130056A1 (en) 2012-02-29 2012-02-29 Use of starfruit extract as a cpt-1 modulator and compositions thereof

Publications (2)

Publication Number Publication Date
BR112014019602A2 BR112014019602A2 (en) 2017-06-20
BR112014019602A8 true BR112014019602A8 (en) 2017-07-11

Family

ID=49083096

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014019602A BR112014019602A8 (en) 2012-02-29 2012-02-29 USE OF CARAMBOLA EXTRACT AS A CPT1 MODULATOR AND COMPOSITIONS THEREOF

Country Status (7)

Country Link
EP (1) EP2819684A4 (en)
JP (1) JP2015508815A (en)
CN (1) CN104125832A (en)
BR (1) BR112014019602A8 (en)
CA (1) CA2863591A1 (en)
MX (1) MX2014009188A (en)
WO (1) WO2013130056A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104125848A (en) * 2012-02-29 2014-10-29 雅芳产品公司 Use of CPT-1 modulators and compositions thereof
WO2015041514A1 (en) * 2013-09-19 2015-03-26 Forest Research Institute Malaysia Averrhoa carambola extract and a method for producing the extract
KR102096204B1 (en) * 2019-05-31 2020-04-02 최명석 Localized fat destroying method and hypotonic solution for destroying localized fat

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4658348B2 (en) * 2001-02-02 2011-03-23 丸善製薬株式会社 Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like agent, and skin cosmetics
JP4953512B2 (en) * 2001-02-13 2012-06-13 丸善製薬株式会社 Testosterone 5α-reductase inhibitor, androgen receptor binding inhibitor, antiandrogen, hair cosmetics, prostate hypertrophy inhibitor
JP4889068B2 (en) * 2001-04-02 2012-02-29 丸善製薬株式会社 Histamine release inhibitor, cyclic AMP phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger
JP2003238379A (en) * 2002-02-08 2003-08-27 Maruzen Pharmaceut Co Ltd Skin care preparation and hair cosmetic
CA2529953A1 (en) * 2003-06-23 2004-12-29 Transpharma Medical Ltd. Transdermal delivery system for cosmetic agents
WO2006053415A1 (en) * 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof
JP4822718B2 (en) * 2005-03-16 2011-11-24 丸善製薬株式会社 Novel C-glycoside compounds, collagen production promoters, skin cosmetics and cosmetic foods and drinks
KR101277162B1 (en) * 2007-03-30 2013-06-19 (주)아모레퍼시픽 Cosmetic composition for slimming
KR20080105470A (en) * 2007-05-31 2008-12-04 (주)아모레퍼시픽 Food composition containing ginseng fruit extract for preventing and improving obesity
JP2009191039A (en) * 2008-02-15 2009-08-27 Maruzen Pharmaceut Co Ltd EXPRESSION PROMOTOR FOR HYALURONIC ACID SYNTHETASE 3mRNA, EXPRESSION PROMOTOR FOR AQUAPORIN 3mRNA, EXPRESSION PROMOTOR FOR SERINE PALMITOYLTRANSFERASE mRNA, AND PRODUCTION PROMOTOR FOR LAMININ 5
FR2939316B1 (en) * 2008-12-05 2012-08-10 Limousine D Applic Biolog Ditesilab Soc Ind COSMETIC USE OF ACTIVATORS OF AUTOPHAGIA OF SKIN CELLS.
JP2010178736A (en) * 2009-01-06 2010-08-19 Zenyaku Kogyo Kk Skin beauty-ameliorating agent, antioxidant, skin beauty-ameliorating composition, or cosmetic food/drink
JP2011105703A (en) * 2009-10-21 2011-06-02 Taisho Pharmaceutical Co Ltd Lipid absorption inhibitor
JP4666537B1 (en) * 2010-01-21 2011-04-06 株式会社資生堂 Wrinkle improving beauty set and beauty method using the same
EP2579843A4 (en) * 2010-06-11 2015-12-16 Avon Prod Inc Use of eclipta prostrata and other ppar-gamma inhibitors in cosmetics and compositions thereof
JP2011055837A (en) * 2010-10-25 2011-03-24 Maruzen Pharmaceut Co Ltd Food and drink for beautification

Also Published As

Publication number Publication date
EP2819684A1 (en) 2015-01-07
CN104125832A (en) 2014-10-29
JP2015508815A (en) 2015-03-23
CA2863591A1 (en) 2013-09-06
EP2819684A4 (en) 2015-12-16
MX2014009188A (en) 2014-08-27
BR112014019602A2 (en) 2017-06-20
WO2013130056A1 (en) 2013-09-06

Similar Documents

Publication Publication Date Title
BR112015021033A8 (en) cosmetic composition, methods for regulating or preventing a skin condition, for reducing or treating signs of skin aging and for preventing, lightening or reducing the appearance of visible skin discontinuities and uses of a composition
BR112012026875A2 (en) use of eclipta prostrata and other ppar-gamma inhibitors in cosmetics and their compositions.
BR112014019167A8 (en) USE OF PALMITOYL TRANSFERASE-1 (CPT-1) CARNITINE MODULATORS TO TREAT SKIN CONDITION DEFINED BY EXCESSIVE OR INSUFFICIENT SUBCUTANEOUS LIPIDS AND TO REDUCE CELLULITE RECURRENCE, AS WELL AS COSMETIC COMPOSITIONS COMPRISING SUCH MODULATORS AND METHOD TO IDENTIFY THEM
BR112013018918A2 (en) nanoparticle compositions
BR112013025493A2 (en) topically administrable aqueous composition for a human or animal eye, method for treating a condition involving deficiencies in natural tears in the human or animal eye, composition for topical application in the treatment of an ocular disorder or condition of the human or animal eye, method for treating an eye or human eye disorder or condition, a composition for use in treating or associated with eye or human eye pain and a method for relieving or approaching eye or human eye pain
BR112015010772A2 (en) topical rinse composition, use of a composition and method for treating or improving an individual's skin against acne
FR2969495B1 (en) EXTRACT OF MACA-RICH AERIAL PARTS OF POLYPHENOLS AND COMPOSITION COMPRISING THE SAME
WO2012005876A3 (en) Compositions and methods for stimulating magp-1 to improve the appearance of skin
WO2012153064A3 (en) Cosmetic or dermatological composition made from extracts of everlasting and use thereof
MX2016003091A (en) A composition comprising guacatonga extract and aroeira extract, use thereof for preventing and/or treating skin ageing.
MX362488B (en) Treating hair loss and delaying aging of skin.
BR112014002595A2 (en) use of sphinganine to improve the visual appearance of skin and hair
BR112015023987A2 (en) two stage toothpaste
WO2015017529A3 (en) Compositions and methods for modulating thermogenesis using pth-related and egf-related molecules
BR112016001919A2 (en) cosmetic composition and cosmetic treatment process
BR112015029815A2 (en) cosmetic composition for lightening an individual's skin and / or hair, set for lightening an individual's skin and / or hair, cosmetic method for lightening an individual's skin and / or hair, cosmetic or pharmaceutical composition for application in skin, hair and / or nail of an individual, combined to apply a cosmetic or pharmaceutical composition to an individual's hair and / or nail skin and method of administering hydrogen peroxide to the individual's skin, hair and / or nail.
BR112018071492A2 (en) saxifraga extracts for cosmetic and therapeutic use on the skin
CL2018003214A1 (en) Composições cosméticas prebióticas e uso das composições cosméticas prebióticas
BR112014011481A2 (en) collagen hydrolyzate and its use
WO2013190567A3 (en) Composition and method for an intradermal hair growth solution
BR112014019602A8 (en) USE OF CARAMBOLA EXTRACT AS A CPT1 MODULATOR AND COMPOSITIONS THEREOF
BR112013003846A2 (en) Cellulite Treatment Methods
WO2014102483A3 (en) Cosmetic or dermatological composition made of iris extracts and use thereof
BR112015017119A8 (en) cosmetic composition, non-therapeutic cosmetic processes for the care and / or makeup of a keratin material, to limit skin darkening and to prevent and / or treat the signs of aging and uses of a cosmetic composition.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2503 DE 26-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.